SI2491005T1 - Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja - Google Patents

Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja

Info

Publication number
SI2491005T1
SI2491005T1 SI201030752T SI201030752T SI2491005T1 SI 2491005 T1 SI2491005 T1 SI 2491005T1 SI 201030752 T SI201030752 T SI 201030752T SI 201030752 T SI201030752 T SI 201030752T SI 2491005 T1 SI2491005 T1 SI 2491005T1
Authority
SI
Slovenia
Prior art keywords
šethyl
ammonioćbutanoate
dimethyl
treatment
cardiovascular disease
Prior art date
Application number
SI201030752T
Other languages
English (en)
Inventor
Ivars Kalvins
Maija Dambrova
Edgars Liepins
Osvalds Pugovics
Reinis Vilskersts
Janis Kuka
Solveiga Grinberga
Einars Loza
Original Assignee
Grindeks, A Joint Stock Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks, A Joint Stock Company filed Critical Grindeks, A Joint Stock Company
Publication of SI2491005T1 publication Critical patent/SI2491005T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SI201030752T 2009-10-22 2010-10-22 Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja SI2491005T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LVP-09-181A LV14345B (lv) 2009-10-22 2009-10-22 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
PCT/EP2010/065924 WO2011048201A1 (en) 2009-10-22 2010-10-22 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
EP10773886.6A EP2491005B1 (en) 2009-10-22 2010-10-22 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Publications (1)

Publication Number Publication Date
SI2491005T1 true SI2491005T1 (sl) 2014-12-31

Family

ID=43530044

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201030752T SI2491005T1 (sl) 2009-10-22 2010-10-22 Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja

Country Status (33)

Country Link
US (2) US9278907B2 (sl)
EP (1) EP2491005B1 (sl)
JP (1) JP5552169B2 (sl)
KR (1) KR101355417B1 (sl)
CN (1) CN102666476B (sl)
AR (1) AR081514A1 (sl)
AU (1) AU2010309756B2 (sl)
BR (1) BR112012009162B8 (sl)
CA (1) CA2781499C (sl)
CL (1) CL2012001010A1 (sl)
CO (1) CO6531459A2 (sl)
CU (1) CU20120065A7 (sl)
DK (1) DK2491005T3 (sl)
EA (1) EA020303B1 (sl)
ES (1) ES2508117T3 (sl)
GE (1) GEP20146123B (sl)
HK (1) HK1169824A1 (sl)
HR (1) HRP20140964T1 (sl)
IL (1) IL219217A0 (sl)
LV (1) LV14345B (sl)
ME (1) ME01917B (sl)
MX (1) MX2012004630A (sl)
NZ (1) NZ599521A (sl)
PE (1) PE20121473A1 (sl)
PL (1) PL2491005T3 (sl)
PT (1) PT2491005E (sl)
RS (1) RS53620B1 (sl)
SI (1) SI2491005T1 (sl)
SM (1) SMT201400176B (sl)
TN (1) TN2012000174A1 (sl)
UA (1) UA107201C2 (sl)
WO (1) WO2011048201A1 (sl)
ZA (1) ZA201202916B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565150B2 (en) * 2009-03-11 2013-10-22 At&T Mobility Ii Llc Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment
EA023547B1 (ru) * 2011-04-27 2016-06-30 Гриндекс, Джоинт Сток Кампани Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания
DE102012109911A1 (de) 2011-10-19 2013-04-25 Electronics And Telecommunications Research Institute Energy harvesting device using electromagnetic interference signal and sensor system including the same
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) * 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه
CN107879944B (zh) * 2017-10-30 2020-05-22 杭州海尔希畜牧科技有限公司 一种制备丁基甜菜碱的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (sl) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4933103A (en) * 1987-03-23 1990-06-12 Kao Corporation Bleaching composition
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JPH0291049A (ja) * 1988-09-21 1990-03-30 Lonza Ag r―ブチロベタインの製造方法
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
JP2000239239A (ja) * 1999-02-22 2000-09-05 Kankyo Meneki Gijutsu Kenkyusho:Kk クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN101538214A (zh) * 2009-04-24 2009-09-23 潍坊祥维斯化学品有限公司 生产γ-丁基甜菜碱及其盐酸盐的方法
BR112013027075A2 (pt) * 2011-04-27 2016-12-27 Grindeks Jsc 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares

Also Published As

Publication number Publication date
PT2491005E (pt) 2014-10-29
UA107201C2 (uk) 2014-12-10
CU20120065A7 (es) 2012-06-29
JP5552169B2 (ja) 2014-07-16
AU2010309756A1 (en) 2012-05-17
BR112012009162A2 (pt) 2020-08-18
US9278907B2 (en) 2016-03-08
TN2012000174A1 (en) 2013-12-12
RS53620B1 (en) 2015-04-30
EA201200514A1 (ru) 2012-09-28
SMT201400176B (it) 2015-01-15
EA020303B1 (ru) 2014-10-30
CA2781499A1 (en) 2011-04-28
ZA201202916B (en) 2013-05-29
CN102666476B (zh) 2014-07-09
DK2491005T3 (da) 2014-10-27
EP2491005A1 (en) 2012-08-29
HRP20140964T1 (hr) 2014-12-05
WO2011048201A1 (en) 2011-04-28
CN102666476A (zh) 2012-09-12
GEP20146123B (en) 2014-07-25
US9573882B2 (en) 2017-02-21
ES2508117T3 (es) 2014-10-16
LV14345A (lv) 2011-05-20
NZ599521A (en) 2013-11-29
ME01917B (me) 2015-05-20
HK1169824A1 (en) 2013-02-08
CO6531459A2 (es) 2012-09-28
CU24114B1 (sl) 2015-08-27
CL2012001010A1 (es) 2012-08-31
PE20121473A1 (es) 2012-11-18
AR081514A1 (es) 2012-10-03
AU2010309756B2 (en) 2013-10-17
KR20120101634A (ko) 2012-09-14
MX2012004630A (es) 2013-07-29
JP2013508342A (ja) 2013-03-07
BR112012009162B1 (pt) 2021-02-02
CA2781499C (en) 2015-03-24
EP2491005B1 (en) 2014-07-23
IL219217A0 (en) 2012-06-28
LV14345B (lv) 2011-07-20
US20120220656A1 (en) 2012-08-30
US20160137589A1 (en) 2016-05-19
KR101355417B1 (ko) 2014-01-27
BR112012009162B8 (pt) 2021-07-27
PL2491005T3 (pl) 2015-03-31

Similar Documents

Publication Publication Date Title
IL216128A (en) Antibodies to ngf with increased in vivo stability
EP2501352A4 (en) WITHDRAWAL OF NON-INVASIVE GREASE
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
IL214133A0 (en) Skin treatment
EP2451347A4 (en) NON-INVASIVE MEASUREMENT OF A PHYSIOLOGICAL PROCESS
SI2491005T1 (sl) Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja
GB0900599D0 (en) Treatment
IL207247A0 (en) Use of ranolazine for the treatment of cardiovascular disease
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
GB0908425D0 (en) Medical use
GB201001521D0 (en) Treatment
GB0913968D0 (en) Treatment
EP2363132A4 (en) USE OF SOPHORICOSIDE IN DRUG MANUFACTURE
HK1173995A1 (en) Use of ferroquine in the treatment of malaria
ZA201307847B (en) 4-(haldalkyl)(dimethyl) ammonio) butandates and use thereof in the treatment of cardiovascular disease
ZA201005770B (en) The treatment of damaged skin
GB0820562D0 (en) Novel use and treatment
GB0809319D0 (en) The treatment of puritus
GB0716840D0 (en) Treatment of cardiovascular disease
GB0922098D0 (en) Therapeutic use
GB0906703D0 (en) Excipients and their use
IL219775A0 (en) Non-invasive fat removal
GB0915801D0 (en) Theraputic treatment
HU0900041D0 (en) Crinoline
GB0913300D0 (en) Therapeutic compounds and their use